Skip to main content
placeholder image

An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP.

Journal Article


Abstract


  • Two hundred and twenty seven patients with stage IIIA-IVB Hodgkin's disease have been treated at a single centre with MVPP chemotherapy followed by radiotherapy to sites of previously bulk disease. The median follow up is 58 months. 119 patients (52%) had stage IV disease. Overall complete remission (CR) rate was 72%. Discriminant analysis of factors predictive for complete remission showed that low albumin was the only independent factor that predicted a significantly lower chance of CR. Overall five year survival was 73%. A Cox multivariate analysis demonstrated that age greater than 40 years, stage IV disease, presence of bulk disease, low serum IgG and male sex to be variables which independently predicted poorer prognosis in terms of overall survival. Stage IV and lymphocyte depleted or unclassified histologies were independently predictive for poorer progression-free survival. Patient weight greater than 70 kg and stage IV disease were adverse prognostic factors for relapse free survival. Results are compared to other published multivariate analyses of prognostic factors in advanced Hodgkin's disease.

UOW Authors


  •   Ranson, Marie (external author)

Publication Date


  • 1991

Citation


  • Ranson, M. R., Radford, J. A., Swindell, R., Deakin, D. P., Wilkinson, P. M., Harris, M., . . . Crowther, D. (1991). An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP.. Annals of oncology : official journal of the European Society for Medical Oncology, 2(6), 423-429. doi:10.1093/oxfordjournals.annonc.a057978

Web Of Science Accession Number


Start Page


  • 423

End Page


  • 429

Volume


  • 2

Issue


  • 6

Abstract


  • Two hundred and twenty seven patients with stage IIIA-IVB Hodgkin's disease have been treated at a single centre with MVPP chemotherapy followed by radiotherapy to sites of previously bulk disease. The median follow up is 58 months. 119 patients (52%) had stage IV disease. Overall complete remission (CR) rate was 72%. Discriminant analysis of factors predictive for complete remission showed that low albumin was the only independent factor that predicted a significantly lower chance of CR. Overall five year survival was 73%. A Cox multivariate analysis demonstrated that age greater than 40 years, stage IV disease, presence of bulk disease, low serum IgG and male sex to be variables which independently predicted poorer prognosis in terms of overall survival. Stage IV and lymphocyte depleted or unclassified histologies were independently predictive for poorer progression-free survival. Patient weight greater than 70 kg and stage IV disease were adverse prognostic factors for relapse free survival. Results are compared to other published multivariate analyses of prognostic factors in advanced Hodgkin's disease.

UOW Authors


  •   Ranson, Marie (external author)

Publication Date


  • 1991

Citation


  • Ranson, M. R., Radford, J. A., Swindell, R., Deakin, D. P., Wilkinson, P. M., Harris, M., . . . Crowther, D. (1991). An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP.. Annals of oncology : official journal of the European Society for Medical Oncology, 2(6), 423-429. doi:10.1093/oxfordjournals.annonc.a057978

Web Of Science Accession Number


Start Page


  • 423

End Page


  • 429

Volume


  • 2

Issue


  • 6